Showing 1 – 20 of 1850
Relevance | Newest | Oldest |
  • Don’t Just Do Something, Stand There!

    Abstract Full Text
    JAMA Intern Med. 2017; 177(10):1420-1421. doi: 10.1001/jamainternmed.2017.3628
  • When Medical Care Leads to Harm—Difficulty Finding Words: A Teachable Moment

    Abstract Full Text
    JAMA Intern Med. 2015; 175(8):1271-1272. doi: 10.1001/jamainternmed.2015.2334
  • Routine Blood Cultures for the Febrile Inpatient: A Teachable Moment

    Abstract Full Text
    is expired quiz
    JAMA Intern Med. 2014; 174(10):1546-1547. doi: 10.1001/jamainternmed.2014.3687
  • First “More,” Then “Less”

    Abstract Full Text
    Arch Intern Med. 2012; 172(6):465-465. doi: 10.1001/archinternmed.2011.2252
  • “Top 5” Lists Top $5 Billion

    Abstract Full Text
    free access
    Arch Intern Med. 2011; 171(20):1858-1859. doi: 10.1001/archinternmed.2011.501
  • Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart Registry

    Abstract Full Text
    free access
    Arch Intern Med. 2011; 171(16):1502-1503. doi: 10.1001/archinternmed.2011.374
  • Do Not Abandon Cultures—Reply

    Abstract Full Text
    Arch Intern Med. 2011; 171(12):1128-1128. doi: 10.1001/archinternmed.2011.261
  • JAMA Internal Medicine March 14, 2011

    Figure 2: Antihypertensive Treatment and Development of Heart Failure in Hypertension: A Bayesian Network Meta-analysis of Studies in Patients With Hypertension and High Cardiovascular Risk

    Network of clinical trials of antihypertensive drugs in which the incidence of heart failure (HF) was reported. For each pair-wise comparison, the arrowhead points to a class of antihypertensive drugs with a lower risk of incident HF in traditional meta-analyses or single trials comparing 2 specific strategies. Summary of odds ratio (OR) and 95% CI for comparison are shown below the arrow. Meta-analyses are performed according to a fixed-effect model, with the exception of those of angiotensin II receptor blockers (ARBs) vs placebo, which was calculated according to a random-effect model (significant heterogeneity present). AB indicates α-blocker; ABCD, Appropriate Blood Pressure Control in Diabetes; ACEI, angiotensin-converting enzyme inhibitor; ALLHAT, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; ANBP2, Second Australian National Blood Pressure Study; ASCOT-BPLA, Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm; BB, β-blocker; CAPPP, Captopril Prevention Project; CCB, calcium-channel blocker; CONVINCE, Controlled Onset Verapamil Investigation of Cardiovascular End Points; CT, conventional treatment; DD, diuretic; E-COST, Efficacy of Candesartan on Outcome in Saitama Trial; FEVER, Felodipine Event Reduction; HOPE, Heart Outcomes Prevention Evaluation; HYVET, Hypertension in the Very Elderly Trial; INSIGHT, Intervention as a Goal in Hypertension Treatment; Jikei, Jikei Heart Study; LIFE, Losartan Intervention For Endpoint; NICS-EH, National Intervention Cooperative Study in Elderly Hypertensives; NORDIL, Nordic Diltiazem; ONTARGET, Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial; RENAAL, Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan; SHELL, Systolic Hypertension in the ELderLy; STOP-2, Swedish Trial in Patients with Hypertension-2; Syst-China, Systolic Hypertension in China; Syst-Eur, Systolic Hypertension in Europe; TRANSCEND, Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease; UKPDS, UK Prospective Diabetes Study; VALUE, Valsartan Antihypertensive Long-term Use Evaluation; and VHAS, Verapamil in Hypertension and Atherosclerosis Study.
  • JAMA Internal Medicine November 12, 2007

    Figure 3: Short- and Long-term Outcomes of Heatstroke Following the 2003 Heat Wave in Lyon, France

    Kaplan-Meier plots showing representative factors influencing probability of survival. A, Origin of admission. Living in an institution before admission for heatstroke was associated with a significantly higher rate of mortality (P < .004 by the log-rank test). B, Long-term use of antihypertensive medication. The absence of an antihypertensive agent was associated with a significantly higher rate of survival (P = .003 by the log-rank test). C, Temperature. Patients with severe hyperthermia (≥ 41°C) had significantly decreased survival (P < .001 by the log-rank test). D, Number of organ dysfunctions. The greater the number of organ dysfunctions at the onset of heatstroke, the more survival decreased (P < .001 by the log-rank test).
  • JAMA Internal Medicine August 14, 2006

    Figure: Etiology and Outcome of Fever After a Stay in the Tropics

    Ranked prevalence of imported febrile diseases (tropical cause in boldface) according to last continent of exposure: top 10 diagnoses. Thirty-seven other patients had visited more than 1 continent, including 5 diagnosed as having Plasmodium falciparum malaria and 1 as having rickettsial infection. *Exclusively Plasmodium vivax malaria.
  • Etiology and Outcome of Fever After a Stay in the Tropics

    Abstract Full Text
    free access
    Arch Intern Med. 2006; 166(15):1642-1648. doi: 10.1001/archinte.166.15.1642
  • JAMA Internal Medicine June 26, 2006

    Figure: Potentially Modifiable Resident Characteristics That Are Associated With Physical or Verbal Aggression Among Nursing Home Residents With Dementia

    Derivation of populations for group 1, data sets for group 1, and group 2. MDS indicates Minimum Data Set. *All residents who had any correction submitted were eliminated, resulting in 0.31% of assessments removed. †All residents who had any correction submitted were eliminated, resulting in 0.30% of assessments removed. ‡Because many residents had more than 1 criterion that would make them ineligible, the exclusions were applied sequentially (thus, these numbers reflect residents eliminated at each step so that no resident is counted in >1 exclusion category). §Variables included activities of daily living, cognition using components of the Cognitive Performance Scale, constipation, delusions, depression using components of the depression scale developed by Burrows et al, fever, sex, hallucinations, urinary tract infection, respiratory tract infection, pain using the scale developed by Fries et al, and physical aggression.
  • A Change of Reason: Medicine and the Scientific Revolution

    Abstract Full Text
    Arch Intern Med. 2006; 166(3):369-370. doi: 10.1001/archinte.166.3.369
  • Signs Masquerading as a Diagnosis

    Abstract Full Text
    Arch Intern Med. 2004; 164(22):2500-2509. doi: 10.1001/archinte.164.22.2502-c
  • Simple Is Beautiful: The Neglected Power of Simple Tests

    Abstract Full Text
    Arch Intern Med. 2004; 164(20):2198-2200. doi: 10.1001/archinte.164.20.2198
  • The Reorganized Risk Factor–Oriented Medical Database: A Progress Report

    Abstract Full Text
    Arch Intern Med. 2004; 164(11):1246-1248. doi: 10.1001/archinte.164.11.1246
  • Death of an Arabian Jew

    Abstract Full Text
    Arch Intern Med. 2004; 164(8):833-839. doi: 10.1001/archinte.164.8.833
  • JAMA Internal Medicine March 22, 2004

    Figure: Differentiating Inhalational Anthrax From Other Influenzalike Illnesses in the Setting of a National or Regional Anthrax Outbreak

    Workup for a febrile patient with an influenzalike illness during an anthrax outbreak. ABGTs indicates arterial blood gas tests; CBCD, complete blood cell and differential counts; CR, chest radiograph; CSF, cerebrospinal fluid; CT, computed tomographic; GS, gram stain; IA, inhalational anthrax; IV, intravenous; LFTs, liver function tests; and RSV, respiratory syncytial virus.
  • An Outbreak of Domestically Acquired Typhoid Fever in Queens, NY

    Abstract Full Text
    Arch Intern Med. 2004; 164(5):565-567. doi: 10.1001/archinte.164.5.565
  • JAMA Internal Medicine September 22, 2003

    Figure 2: Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia

    Association between the Staphylococcus aureus bacteremia (SAB) score and probability of complicated SAB. Staphylococcus aureus bacteremia score = sum of individual risk factor points (1 point for "community-acquired SAB," "skin examination findings suggesting the presence of acute systemic infection," and "persistent fever at 72 hours"; 2 points for "positive follow-up blood culture result at 48-96 hours"). The bars indicate range of predicted probabilities of complicated SAB for each corresponding risk score (only one way to achieve a score of 0, 4, or 5).